AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

OTCMKTS:RHHBYRoche Holdings AG Basel News Headlines

$43.95
+0.86 (+2.00 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$43.70
Now: $43.95
$44.27
50-Day Range
$39.39
MA: $43.45
$45.61
52-Week Range
$32.67
Now: $43.95
$46.00
Volume894,550 shs
Average Volume2.52 million shs
Market Capitalization$300.99 billion
P/E Ratio17.30
Dividend Yield1.64%
Beta0.41

Headlines

Roche Holdings AG Basel (OTCMKTS RHHBY) News Headlines

Source:
DateHeadline
FDA Approves Genentech’s Tecentriq in Combination With Avastin for People With the Most Common Form of Liver CancerFDA Approves Genentech’s Tecentriq in Combination With Avastin for People With the Most Common Form of Liver Cancer
finance.yahoo.com - May 29 at 3:07 PM
Updated data demonstrate Roche’s Alecensa increases overall survival rate for people with ALK-positive non-small cell lung cancerUpdated data demonstrate Roche’s Alecensa increases overall survival rate for people with ALK-positive non-small cell lung cancer
finance.yahoo.com - May 29 at 10:06 AM
CHMP recommends EU approval of Roche’s Rozlytrek for people with NTRK fusion-positive solid tumours and for people with ROS1-positive, advanced non-small cell lung cancerCHMP recommends EU approval of Roche’s Rozlytrek for people with NTRK fusion-positive solid tumours and for people with ROS1-positive, advanced non-small cell lung cancer
finance.yahoo.com - May 29 at 10:06 AM
Port Delivery System With Ranibizumab Shows Positive Phase III Results in Neovascular Age-Related Macular DegenerationPort Delivery System With Ranibizumab Shows Positive Phase III Results in Neovascular Age-Related Macular Degeneration
finance.yahoo.com - May 27 at 4:36 AM
Roche’s Port Delivery System with ranibizumab shows positive phase III results in neovascular age-related macular degenerationRoche’s Port Delivery System with ranibizumab shows positive phase III results in neovascular age-related macular degeneration
finance.yahoo.com - May 27 at 4:36 AM
Tubeless Insulin Pump Market Insights and Global Outlook During 2020 to 2026; Johnson & Johnson(NYSE:JNJ), Roche Holding AG ADR(OTC:RHHBY)Tubeless Insulin Pump Market Insights and Global Outlook During 2020 to 2026; Johnson & Johnson(NYSE:JNJ), Roche Holding AG ADR(OTC:RHHBY)
www.marketwatch.com - May 25 at 5:40 PM
New Longer-Term Data Reinforce Safety of Genentech’s Satralizumab in Adults and Adolescents With Neuromyelitis Optica Spectrum Disorder (NMOSD)New Longer-Term Data Reinforce Safety of Genentech’s Satralizumab in Adults and Adolescents With Neuromyelitis Optica Spectrum Disorder (NMOSD)
finance.yahoo.com - May 23 at 8:01 AM
New longer-term data reinforce safety of Roche’s satralizumab in adults and adolescents with neuromyelitis optica spectrum disorderNew longer-term data reinforce safety of Roche’s satralizumab in adults and adolescents with neuromyelitis optica spectrum disorder
finance.yahoo.com - May 23 at 8:01 AM
Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic useRoche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use
finance.yahoo.com - May 23 at 8:01 AM
Roche Acquires Stratos Genomics, Presents Data on NMOSD DrugRoche Acquires Stratos Genomics, Presents Data on NMOSD Drug
finance.yahoo.com - May 22 at 12:50 PM
Roche Holdings AG Basel ADR (OTCMKTS:RHHBY) Receives Average Recommendation of "Buy" from AnalystsRoche Holdings AG Basel ADR (OTCMKTS:RHHBY) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 21 at 4:28 AM
Roche highly accurate antibody test for COVID-19 goes live at more than 20 initial lab sites in the USRoche highly accurate antibody test for COVID-19 goes live at more than 20 initial lab sites in the US
finance.yahoo.com - May 19 at 5:58 PM
Roche's Tecentriq Gets FDA Approval for Metastatic NSCLCRoche's Tecentriq Gets FDA Approval for Metastatic NSCLC
finance.yahoo.com - May 19 at 12:57 PM
Our Chief Picks In PharmaOur Chief Picks In Pharma
seekingalpha.com - May 19 at 7:50 AM
FDA approves Roche’s Tecentriq as a first-line monotherapy for certain people with metastatic non-small cell lung cancerFDA approves Roche’s Tecentriq as a first-line monotherapy for certain people with metastatic non-small cell lung cancer
finance.yahoo.com - May 19 at 1:42 AM
FDA Approves Genentech’s Tecentriq as a First-Line Monotherapy for Certain People With Metastatic Non-Small Cell Lung CancerFDA Approves Genentech’s Tecentriq as a First-Line Monotherapy for Certain People With Metastatic Non-Small Cell Lung Cancer
finance.yahoo.com - May 18 at 3:41 PM
Roche Holdings AG Basels (RHHBY) "Overweight" Rating Reiterated at BarclaysRoche Holdings AG Basel's (RHHBY) "Overweight" Rating Reiterated at Barclays
www.americanbankingnews.com - May 15 at 3:57 PM
Roche launches new blood gas digital solution designed to improve patient careRoche launches new blood gas digital solution designed to improve patient care
finance.yahoo.com - May 15 at 3:14 AM
Britain in talks with Roche on ‘game changer’ COVID-19 antibody testBritain in talks with Roche on ‘game changer’ COVID-19 antibody test
www.theglobeandmail.com - May 14 at 12:12 PM
UK follows EU, U.S. to approve Roche COVID-19 antibody testsUK follows EU, U.S. to approve Roche COVID-19 antibody tests
www.reuters.com - May 14 at 12:12 PM
Relaxing the Lockdown: Move Slowly, Stay NimbleRelaxing the Lockdown: Move Slowly, Stay Nimble
finance.yahoo.com - May 14 at 12:12 PM
Roche to present first clinical data on novel anti-TIGIT cancer immunotherapy tiragolumab at ASCORoche to present first clinical data on novel anti-TIGIT cancer immunotherapy tiragolumab at ASCO
finance.yahoo.com - May 14 at 2:09 AM
Wolfe Research Upgrades Roche Holdings AG Basel (OTCMKTS:RHHBY) to OutperformWolfe Research Upgrades Roche Holdings AG Basel (OTCMKTS:RHHBY) to Outperform
www.americanbankingnews.com - May 13 at 4:57 PM
Fritz Gerber, Former CEO of Swiss Drugmaker Roche, Dies at 91Fritz Gerber, Former CEO of Swiss Drugmaker Roche, Dies at 91
www.wsj.com - May 13 at 4:08 PM
Changes to the Roche Enlarged Corporate Executive CommitteeChanges to the Roche Enlarged Corporate Executive Committee
finance.yahoo.com - May 11 at 2:14 AM
Roche's U.S. gRED research head to retire, be replaced by MIT's RegevRoche's U.S. gRED research head to retire, be replaced by MIT's Regev
finance.yahoo.com - May 11 at 2:14 AM
New data at the ASCO20 Virtual Scientific Program reflects Roche’s commitment to accelerating progress in cancer careNew data at the ASCO20 Virtual Scientific Program reflects Roche’s commitment to accelerating progress in cancer care
finance.yahoo.com - May 7 at 11:12 PM
PTC Therapeutics (PTCT) Q1 2020 Earnings Call TranscriptPTC Therapeutics (PTCT) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 4 at 6:36 AM
U.S.-China Tensions Flare Anew, Buffett Dumps Airlines, FDA OKs Roche Antibody Test - 5 Things You Must Know MondayU.S.-China Tensions Flare Anew, Buffett Dumps Airlines, FDA OKs Roche Antibody Test - 5 Things You Must Know Monday
finance.yahoo.com - May 4 at 6:36 AM
Roche Gets Emergency FDA Approval For Covid-19 Antibody Test, Starts ShippingRoche Gets Emergency FDA Approval For Covid-19 Antibody Test, Starts Shipping
finance.yahoo.com - May 3 at 3:34 PM
FDA Grants Roche Emergency Approval for Antibody TestFDA Grants Roche Emergency Approval for Antibody Test
finance.yahoo.com - May 3 at 3:34 PM
Roche wins U.S. nod for COVID-19 antibody test, aims to boost outputRoche wins U.S. nod for COVID-19 antibody test, aims to boost output
finance.yahoo.com - May 3 at 9:05 AM
Roche gets FDA emergency use nod for COVID-19 antibody testRoche gets FDA emergency use nod for COVID-19 antibody test
www.reuters.com - May 3 at 3:51 AM
Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE markRoche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark
finance.yahoo.com - May 2 at 10:51 PM
Roche gets FDA emergency use approval for COVID-19 antibody testRoche gets FDA emergency use approval for COVID-19 antibody test
finance.yahoo.com - May 2 at 10:51 PM
Amgen Stock Jumps on Earnings, Covid-19 Trial AnnouncementAmgen Stock Jumps on Earnings, Covid-19 Trial Announcement
finance.yahoo.com - April 30 at 5:58 PM
The Daily Biotech Pulse: Pfizer Earnings, Roches Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine UpdateThe Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update
www.benzinga.com - April 28 at 7:43 AM
Genentech’s Risdiplam Shows Significant Improvement in Survival and Motor Milestones in Infants With Type 1 Spinal Muscular Atrophy (SMA)Genentech’s Risdiplam Shows Significant Improvement in Survival and Motor Milestones in Infants With Type 1 Spinal Muscular Atrophy (SMA)
finance.yahoo.com - April 28 at 2:42 AM
Roche’s risdiplam shows significant improvement in survival and motor milestones in infants with Type 1 spinal muscular atrophy (SMA)Roche’s risdiplam shows significant improvement in survival and motor milestones in infants with Type 1 spinal muscular atrophy (SMA)
finance.yahoo.com - April 28 at 2:42 AM
New 6-year data for Roche’s OCREVUS (ocrelizumab) show earlier treatment initiation nearly halves risk of needing walking aid in relapsing multiple sclerosisNew 6-year data for Roche’s OCREVUS (ocrelizumab) show earlier treatment initiation nearly halves risk of needing walking aid in relapsing multiple sclerosis
finance.yahoo.com - April 28 at 2:42 AM
New 6-year Data for Genentech’s Ocrevus (ocrelizumab) Show Earlier Treatment Initiation Nearly Halves Risk of Needing Walking Aid in Relapsing Multiple SclerosisNew 6-year Data for Genentech’s Ocrevus (ocrelizumab) Show Earlier Treatment Initiation Nearly Halves Risk of Needing Walking Aid in Relapsing Multiple Sclerosis
finance.yahoo.com - April 28 at 2:42 AM
Roche says risdiplam effective in spinal muscular atrophy trialRoche says risdiplam effective in spinal muscular atrophy trial
finance.yahoo.com - April 28 at 2:42 AM
The Zacks Analyst Blog Highlights: Facebook, Roche, Royal Dutch Shell, Uber Technologies and Lam ResearchThe Zacks Analyst Blog Highlights: Facebook, Roche, Royal Dutch Shell, Uber Technologies and Lam Research
finance.yahoo.com - April 27 at 11:40 AM
'A disaster': Roche CEO's verdict on some COVID-19 antibody tests'A disaster': Roche CEO's verdict on some COVID-19 antibody tests
finance.yahoo.com - April 22 at 7:45 AM
Roche to Launch Virus Antibody Test at Start of May: CEORoche to Launch Virus Antibody Test at Start of May: CEO
finance.yahoo.com - April 22 at 7:45 AM
Roche chief criticises UK’s under-investment in healthcareRoche chief criticises UK’s under-investment in healthcare
finance.yahoo.com - April 22 at 7:45 AM
First quarter with 2% growth in Swiss francs, 7% at constant exchange ratesFirst quarter with 2% growth in Swiss francs, 7% at constant exchange rates
finance.yahoo.com - April 22 at 1:17 AM
Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancerRoche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer
finance.yahoo.com - April 21 at 10:17 AM
Seattle Genetics Gets Early FDA Nod for Breast Cancer DrugSeattle Genetics Gets Early FDA Nod for Breast Cancer Drug
finance.yahoo.com - April 20 at 1:36 PM
US FDA and EMA accept applications for Roche’s OCREVUS (ocrelizumab) shorter 2-hour infusion timeUS FDA and EMA accept applications for Roche’s OCREVUS (ocrelizumab) shorter 2-hour infusion time
finance.yahoo.com - April 20 at 8:36 AM
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.